Why the study?
Does previous statin use affect the risk of sICH and favorable 3-month outcome in patients receiving intravenous thrombolysis for ischemic stroke?
Does previous statin use affect the risk of sICH and favorable 3-month outcome in patients receiving intravenous thrombolysis for ischemic stroke?
While higher statin doses may increase the risk of sICH after IV thrombolysis for ischemic stroke, prior statin use overall improves 3-month outcomes.
No takes yet. Share an insight, caveat, or question.
Prior statin use may improve 3-month outcomes despite dose-related sICH risk after IV thrombolysis; leaves open causal effects and optimal management.
Scheitz et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: